On March 16, the reporter of China Securities Journal learned from Lbx Pharmacy Chain Joint Stock Company(603883) that the first batch of covid-19 antigen detection products had passed the quality acceptance and had been put on the shelves of the company’s stores in Tianjin for sale.
It is understood that the Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy supply the Tianjin market New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) produced by Tianjin Bo OSI biological Polytron Technologies Inc, which is also the reason why Tianjin’s market energy rate is first laid out. Next, Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy stores located in more than 20 provinces and cities across the country will also start selling one after another.
